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Background

Results

HPV is the most common STD in the United States
with nearly 14 million people infected annually. It is
responsible for nearly all cases of cervical cancer
and five other cancers.1 The CDC recommends
routine vaccines through the age of 26; however,
completion rates remain low, while HPV infection
rates remain high among 18- to 26-year-olds.2
Educational interventions have been shown to
improve immunization uptake by influencing
knowledge and attitudes.3,4 However, it is not clear
the extent to which instruments used in these
interventions are validated.
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Purpose
The purpose of this review is to identify the
outcomes measured in HPV vaccination
interventions conducted among young adults and
the instruments used. Additionally, we will assess
the extent to which the instruments used are
validated.

Table 1. Examples of HPV Intervention Characteristics
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2020
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• Databases Searched: PubMed, Web of
•

•

Science, Embase, Cochrane
Inclusion criteria:
• Focused on HPV vaccination
interventions
• Examined young adults aged 18-26
• Occurred after FDA approval of the HPV
vaccine in 2006
• Conducted within the United States
• Peer-reviewed
• Used quantitative or mixed-method
approaches
Reliability and Blinding: All of the articles were
double-reviewed for reliability at each stage

• Common outcomes: HPV

Author, Year, Study Design Intervention(I) and control
Journal
(C)
Gerend et al., RCT
2009
Sexually
Transmitted
Diseases

Chan et al.,
2015
BMC
research
notes

I- 2 page intervention
message on HPV infection
(self protection and partner
protection); C-HPV self
protection message

I- Weekly electronic
newsletters and interactive
Facebook posts relevant to
college students
contemplating HPV
vaccination; C- weekly
newsletters and facebook
posts related to healthy
eating, activity, and weight
control practices
PreI- 18-page fotonovela on
experimental importance of HPV
vaccination (english &
spanish versions); C- no
control

Doherty et al., RCT
2008
International
Journal of
Sexual Health

I- educational website in
form of HPV information
FAQ sheet (question and
answer section, personal
story, self-quiz); C- no
educational website

Outcome

•
Population (P) & Sample
Size (S)

Setting

knowledge, intention,
susceptibility, self-efficacy, and
social norms.
Most used RCT study design and
were adapted from previous
research and validated models,
such as the Health Belief Model
Validity not reported for most
Results

Validity (whether
report validity or not Chronbach Alpha)

Vaccine
awareness/knowledge,
Vaccine acceptability

P- Heterosexual male
University Knowledge increased from
college students (18-24); S=
baseline: F (1354) =893.6, P
356
<0.001.

Reported for some
measures; health
beliefs and intention:
.79-.94. Not reported for
knowledge and
awareness

HPV vaccination knowledge,
attitudes, behaviors,
intervention engagement and
treatment satisfaction,
vaccination status and
intentions

P- Undergraduate students University Knowledge improvement
Reported adapted from
enrolled in an advanced
statistically significant in
previously validated
health communication
intervention compared to control. measures
course (18-25); S=58

Perceptions of susceptibility to P- Male and female young Healthcare Improvement across all outcome Not reported
disease, perceptions of
adults in a low-income
/Clinic
variables. Statistically significant
benefits of the health action, primary care clinic in
improvement for susceptibility
intent to vaccinate, intent to
Southern California (18–
and attitude (P < 0.05). Increase
encourage others to vaccinate, 26); S=41
in knowledge.
knowledge
Knowledge of HPV, knowledge P- Male and female
University More positive attitudes,
of risk factors for cervical
undergraduate students
increased perceptions of risk,
cancer, beliefs about perceived from 3 intro psychology
greater personal susceptibility to
susceptibility to HPV, attitudes courses and 1 abnormal
HPV than the controls at followtoward HPV vaccination
psychology course; S= 119
up, increased knowledge. No
(51 males and 68 females)
difference in behavioral
outcomes.

Knowledge: α = .82, risk
factors for cervical
cancer: α = .66, beliefs
about risk of HPV: α =
.62, attitudes toward
HPV vaccination: α =
.70

Based on preliminary data extraction:
• 33 studies met the inclusion criteria.
• Majority of these studies were conducted in
populations which are often identified as
having lower uptake and are at a greater risk
for infection.
• Lack of validation limits comparison and
raises questions about the validity of findings.
• Review will improve the quality of HPV
vaccination promotion research by clarifying
the status of HPV vaccination research.
• Results suggest the need for the
development of validated instruments to
measure HPV intervention outcomes.

Responsible Conduct of
Research
The systematic review followed PRISMA
protocol. No IRB approval was required.
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